FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: an Austrian observational Tri-Center comparative effectiveness analysis [Abstract]
| Author: | J. Riedl, F. Posch, L. Horvath, A. Gantschnigg, F. Renneberg, E. Schwarzenbacher, F. Moik, D. Barth, R. Schaberl-Moser, M. Stotz, Martin PichlerGND, H. Stöger, R. Greil, A. Djanani, K. Schlick, A. Gerger |
|---|---|
| Frontdoor URL | https://opus.bibliothek.uni-augsburg.de/opus4/101731 |
| ISSN: | 2296-5262OPAC |
| Parent Title (English): | Oncology Research and Treatment |
| Publisher: | Karger |
| Place of publication: | Basel |
| Type: | Article |
| Language: | English |
| Date of Publication (online): | 2023/02/06 |
| Year of first Publication: | 2020 |
| Publishing Institution: | Universität Augsburg |
| Release Date: | 2023/02/06 |
| Volume: | 43 |
| Issue: | Suppl. 4 |
| First Page: | 215 |
| DOI: | https://doi.org/10.1159/000510995 |
| Institutes: | Medizinische Fakultät |
| Medizinische Fakultät / Universitätsklinikum | |
| Medizinische Fakultät / Professur für Translationale Krebsforschung |
